
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Reprogramming of tumor-associated macrophages via NEDD4-mediated CSF1R degradation by targeting USP18
Sayuri Miyauchi, Kei‐ichiro Arimoto, Mengdan Liu, et al.
Cell Reports (2023) Vol. 42, Iss. 12, pp. 113560-113560
Open Access | Times Cited: 13
Sayuri Miyauchi, Kei‐ichiro Arimoto, Mengdan Liu, et al.
Cell Reports (2023) Vol. 42, Iss. 12, pp. 113560-113560
Open Access | Times Cited: 13
Showing 13 citing articles:
Emerging role of immunogenic cell death in cancer immunotherapy
Kei‐ichiro Arimoto, Sayuri Miyauchi, Mengdan Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
Kei‐ichiro Arimoto, Sayuri Miyauchi, Mengdan Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
In the moonlight: non-catalytic functions of ubiquitin and ubiquitin-like proteases
Marta Campos Alonso, Klaus‐Peter Knobeloch
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 5
Marta Campos Alonso, Klaus‐Peter Knobeloch
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 5
Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets
Zihang Hong, Furong Liu, Zhanguo Zhang
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Zihang Hong, Furong Liu, Zhanguo Zhang
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Insights into CSF-1R Expression in the Tumor Microenvironment
Caterina Tomassetti, Gaia Insinga, Francesca Gimigliano, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2381-2381
Open Access | Times Cited: 4
Caterina Tomassetti, Gaia Insinga, Francesca Gimigliano, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2381-2381
Open Access | Times Cited: 4
The role of type I interferon signaling in myeloid anti-tumor immunity
Sofie Patrizia Meyer, Rebekka Bauer, Bernhard Brüne, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Sofie Patrizia Meyer, Rebekka Bauer, Bernhard Brüne, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Protease regulation of tumor-immune cell symbiosis
Lizhi Pang, Yu-Yun Huang, Jean Huang-Gao, et al.
Trends in cancer (2025)
Closed Access
Lizhi Pang, Yu-Yun Huang, Jean Huang-Gao, et al.
Trends in cancer (2025)
Closed Access
7aaRGD - a novel SPP1/integrin signaling-blocking peptide reverses immunosuppression and improves anti-PD-1 immunotherapy outcomes in experimental gliomas
Aleksandra Ellert‐Miklaszewska, Paulina Pilanc, Katarzyna Poleszak, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Aleksandra Ellert‐Miklaszewska, Paulina Pilanc, Katarzyna Poleszak, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Parkin activates innate immunity and promotes anti-tumor immune responses
Michela Perego, Minjeong Yeon, Ekta Agarwal, et al.
Journal of Clinical Investigation (2024)
Open Access | Times Cited: 3
Michela Perego, Minjeong Yeon, Ekta Agarwal, et al.
Journal of Clinical Investigation (2024)
Open Access | Times Cited: 3
The ISG15-Protease USP18 Is a Pleiotropic Enhancer of HIV-1 Replication
Chaohui Lin, Edmund Osei Kuffour, Taolan Li, et al.
Viruses (2024) Vol. 16, Iss. 4, pp. 485-485
Open Access | Times Cited: 1
Chaohui Lin, Edmund Osei Kuffour, Taolan Li, et al.
Viruses (2024) Vol. 16, Iss. 4, pp. 485-485
Open Access | Times Cited: 1
Protocol to study the immune profile of syngeneic mouse tumor models
Sayuri Miyauchi, Kei-Ichiro Arimoto, Mengdan Liu, et al.
STAR Protocols (2024) Vol. 5, Iss. 3, pp. 103139-103139
Open Access | Times Cited: 1
Sayuri Miyauchi, Kei-Ichiro Arimoto, Mengdan Liu, et al.
STAR Protocols (2024) Vol. 5, Iss. 3, pp. 103139-103139
Open Access | Times Cited: 1
Integrin blocking peptide reverses immunosuppression in experimental gliomas and improves anti-PD-1 therapy outcome
Aleksandra Ellert‐Miklaszewska, Paulina Pilanc, Katarzyna Poleszak, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Aleksandra Ellert‐Miklaszewska, Paulina Pilanc, Katarzyna Poleszak, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
USP18 Is Associated with PD-L1 Antitumor Immunity and Improved Prognosis in Colorectal Cancer
Cili Jifu, Linxia Lü, Jiaxin Ding, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1191-1191
Open Access
Cili Jifu, Linxia Lü, Jiaxin Ding, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1191-1191
Open Access
7aaRGD - a novel SPP1/integrin signaling-blocking peptide reverses immunosuppression and improves anti-PD-1 immunotherapy outcomes in experimental gliomas
Aleksandra Ellert‐Miklaszewska, Paulina Pilanc, Katarzyna Poleszak, et al.
Research Square (Research Square) (2024)
Closed Access
Aleksandra Ellert‐Miklaszewska, Paulina Pilanc, Katarzyna Poleszak, et al.
Research Square (Research Square) (2024)
Closed Access
Prognostic role of STAT6 in patients with non-small cell lung cancer
О. І. Vynnychenko, Yuliia Moskalenko, О. V. Yazykov, et al.
Regulatory Mechanisms in Biosystems (2024) Vol. 15, Iss. 4, pp. 868-874
Open Access
О. І. Vynnychenko, Yuliia Moskalenko, О. V. Yazykov, et al.
Regulatory Mechanisms in Biosystems (2024) Vol. 15, Iss. 4, pp. 868-874
Open Access